Without doubt future Admedus vaccines will be delivered via nano-patch. There is a video of a seminar at UQ about the nano patch with Frazer on the panel. It solves problems of storage (refrigeration not required), bulk (for transport and storage for mass immunisations in Africa), AND provides a more robust immune response while using less antigen. Immunisation delivered via nano-patch is cheaper, better and easier.
However I don't really need a thread reminding me that Vaxxas is not a listed company and I can't buy into it (in my view an even better prospect than Admedus).
Vaxxas secures funding interest to see if professor Fraser utilizes nanopatch, page-13
-
- There are more pages in this discussion • 105 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |